SBC Medical Group (NASDAQ:SBC) Stock Price Down 13.5% - Should You Sell?

SBC Medical Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • SBC Medical Group shares fell 13.5% to about $5.42, with trading volume 8% above average.
  • The company reported unauthorized access to databases containing customer information tied to some clinics in Japan, raising data-security concerns. Separately, Sidoti raised its FY2026 and FY2027 earnings forecasts.
  • Recent quarterly results beat expectations, with EPS of $0.15 versus $0.12 expected and revenue of $58.58 million versus $48.90 million expected. Analysts’ consensus rating is “Moderate Buy,” with a $10 price target.
  • MarketBeat previews top five stocks to own in December.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) traded down 13.5% on Thursday. The stock traded as low as $5.36 and last traded at $5.4210. Approximately 151,317 shares changed hands during trading, an increase of 8% from the average session volume of 139,592 shares. The stock had previously closed at $6.27.

SBC Medical Group News Summary

These are some of the SBC news items that stood out recently:

  • Positive Sentiment: Sidoti raised its earnings forecasts across several quarters. It now expects FY2026 EPS of $0.51, up from $0.47, and FY2027 EPS of $0.60, up from $0.52. The firm also lifted estimates for individual quarters in late 2026 and 2027, signaling improved expectations for earnings growth.
  • Negative Sentiment: The company reported unauthorized access to certain databases on November 16 involving customer information associated with some clinics in Japan. The disclosure raises concerns about data protection and potential follow-on impacts; the company said it provided an update on its response. SBC Medical Group Reports Cybersecurity Incidents in Japan

Analysts Set New Price Targets

A number of equities analysts have recently commented on SBC shares. BTIG Research raised their target price on shares of SBC Medical Group from $8.00 to $10.00 and gave the stock a "buy" rating in a research report on Friday, November 13th. Wall Street Zen downgraded shares of SBC Medical Group from a "strong-buy" rating to a "buy" rating in a research note on Saturday, November 14th. Finally, Weiss Ratings upgraded shares of SBC Medical Group from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $10.00.

View Our Latest Analysis on SBC Medical Group

SBC Medical Group Stock Performance

The firm's 50 day moving average is $5.24 and its two-hundred day moving average is $4.00. The company has a debt-to-equity ratio of 0.08, a quick ratio of 3.27 and a current ratio of 3.67. The stock has a market capitalization of $574.40 million, a PE ratio of 11.17, a P/E/G ratio of 2.75 and a beta of 0.52.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last issued its earnings results on Friday, November 13th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.03. The business had revenue of $58.58 million during the quarter, compared to analysts' expectations of $48.90 million. SBC Medical Group had a net margin of 27.26% and a return on equity of 18.58%. As a group, research analysts predict that SBC Medical Group Holdings Incorporated will post 0.44 earnings per share for the current year.

Institutional Investors Weigh In On SBC Medical Group

A number of institutional investors and hedge funds have recently bought and sold shares of SBC. New York State Common Retirement Fund acquired a new position in shares of SBC Medical Group during the 3rd quarter valued at about $84,000. Goldman Sachs Group Inc. bought a new stake in shares of SBC Medical Group in the third quarter worth $247,000. Marshall Wace LLP acquired a new stake in SBC Medical Group during the third quarter valued at approximately $520,000. State Street Corp lifted its holdings in shares of SBC Medical Group by 58.9% in the 3rd quarter. State Street Corp now owns 78,232 shares of the company's stock worth $386,000 after purchasing an additional 28,993 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its stake in SBC Medical Group by 2,810.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 125,991 shares of the company's stock valued at $622,000 after purchasing an additional 121,662 shares during the period. Hedge funds and other institutional investors own 60.82% of the company's stock.

About SBC Medical Group

(Get Free Report)

SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SBC Medical Group Right Now?

Before you consider SBC Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.

While SBC Medical Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines